5 results match your criteria: "Michigan Medicine Cancer Genetics Clinic[Affiliation]"
JCI Insight
July 2023
Department of Medicine, Division of Gastroenterology and Hepatology, Arizona Comprehensive Cancer Center, and.
Am J Gastroenterol
November 2022
Section of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, Illinois, USA.
Introduction: Germline variants in CDH1 are associated with elevated risks of diffuse gastric cancer and lobular breast cancer. It is uncertain whether there is an increased risk of colorectal neoplasia.
Methods: This was a retrospective analysis of colonoscopy outcomes in patients with germline CDH1 pathogenic/likely pathogenic variants.
Advances in cancer genetics have increased germline pathogenic/likely pathogenic variant (PV/LPV) detection rates. More data is needed to inform which patients with previously uninformative results could benefit most from retesting, especially beyond breast/ovarian cancer populations. Here, we describe retesting outcomes and predictors of PV/LPVs in a cohort of patients unselected by cancer diagnosis.
View Article and Find Full Text PDF